 
| Course: |
An Evaluation of Restless Leg Syndrome (RLS) |
| Target Audience: |
| Family Medicine/Primary Care Physicians, Nurse Practitioners and Physician Assistants.
Program Overview:
Some patients present unique challenges. Studies have shown that RLS is frequently misdiagnosed, under-diagnosed and poorly managed. This interactive online case simulation is designed to increase your knowledge, competence and performance in diagnosing and treating Restless Leg Syndrome (RLS) and improve the health outcomes of your patients. |
| Sponsor: |
Presented by: National Jewish Health
Grantor:
Supported by an unrestricted educational grant from GlaxoSmithKline.
|
| Accreditation: |
| National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
| Credit Designation: |
| National Jewish Health designates this educational activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. |
| Faculty Listing: |
Cases Developed by Expert National Jewish Health Faculty
John Harrington, MD
Assistant Professor
Sleep Division, Department of Medicine
National Jewish Health
Teofilo Lee-Chiong, MD
Professor of Medicine and
Head, Division of Sleep Medicine
National Jewish Health
Daniel Smith, MD
Assistant Professor
Pulmonary Division, Department of Medicine
National Jewish Health
Harold Nelson, MD
Department of Medicine
Department of Pediatrics
Professor
National Jewish Health |
| Subjects: |
- An Evaluation of Restless Leg Syndrome (RLS)
|
| Objectives: |
- Following completion of this series of case simulations, participants should be able to:
- To recognize the clinical manifestations of Restless Leg Syndrome (RLS)
- To understand the proposed pathophysiology of RLS
- To recognize diagnosis challenges of RLS
- To develop a successful therapy program for RLS
|
| Financial Disclosure: |
In accordance with the Accreditation Council for Continuing Medical Education, National Jewish Health requires that all persons in a position to control the content of a CME activity, including the CME review committee disclose all significant financial interest with commercial interests including the review committee.
John Harrington, MD
Investigator: Actelion, Breathe
Teoflio Lee-Chiong, MD
Consultant: DievielNutrisystems, Covidien
Harold Nelson, MD
Consultant: Abbott, AstraZeneca, Boehringer-Ingelheim, Dey, L.P., Dynavax Technologies, Dyson, Genentech, GlaxoSmithKline, Johnson & Johnson, MediciNova, Novartis, Schering- Plough, Sepracor, Teva
Investigator: Altana, AstraZeneca, Boehringer-Ingelheim, Ception, Genentech, Novartis, Schering-Plough, Sepracor, Wyeth
Speaker: AstraZeneca , GlaxoSmithKline
David Smith, MD
Has no significant financial interest to report.
|
- You are not currently logged in.
- To view content articles and complete the post-test for this course, please login or register now
|
|
